General Information of the Compound
Compound ID
CP0559338
Compound Name
5-(pentylthio)thiazolo[4,5-d]pyrimidin-7-ol
    Show/Hide
Synonyms
5-(pentylthio)thiazolo[4,5-d]pyrimidin-7-ol
    Show/Hide
Structure
Formula
C10H13N3OS2
Molecular Weight
255.368
Canonical SMILES
CCCCCSc1nc2ncsc2c(=O)[nH]1
    Show/Hide
InChI
InChI=1S/C10H13N3OS2/c1-2-3-4-5-15-10-12-8-7(9(14)13-10)16-6-11-8/h6H,2-5H2,1H3,(H,12,13,14)
    Show/Hide
InChIKey
QONMYXCFINJDMT-UHFFFAOYSA-N
Physicochemical Property
logP
2.6619
Rotatable Bonds
5
Heavy Atom Count
16
Polar Areas
58.64
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
16

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 135546485
SID: 14798799
ChEMBL ID
CHEMBL201672
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01013, C-X-C chemokine receptor type 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 5-(pentylthio)thiazolo[4,5-d]pyrimidin-7-ol )
Drug Name 5-(pentylthio)thiazolo[4,5-d]pyrimidin-7-ol
Target(s)
C-X-C chemokine receptor type 2 (CXCR2)
Inhibitor